✦ LIBER ✦
Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10
✍ Scribed by McCahill, L. E.; Yothers, G.; Sharif, S.; Petrelli, N. J.; Lai, L. L.; Bechar, N.; Giguere, J. K.; Dakhil, S. R.; Fehrenbacher, L.; Lopa, S. H.; Wagman, L. D.; O'Connell, M. J.; Wolmark, N.
- Book ID
- 126684496
- Publisher
- American Society of Clinical Oncology
- Year
- 2012
- Tongue
- English
- Weight
- 209 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.